Articles tagged with Myocardial Infarction
Researchers from Florida Atlantic University challenge the current aspirin guidelines based on a flawed trial, advocating for healthcare providers to make individual clinical judgments about prescribing aspirin. They stress that patients should consult their primary care provider to balance the benefits of clot prevention against bleed...
Swedish researchers have identified 20 genetic variants associated with an increased risk of atherosclerosis, a leading cause of cardiovascular disease. The study used advanced imaging techniques to examine millions of genetic variants, providing new insights into the disease process and potential ways to prevent it.
Patients who received nurse-led follow-up care had a 30% lower rate of cardiovascular death, non-fatal heart attacks, or strokes at five years compared to those receiving standard care. This was achieved through improved lifestyle habits and medication adherence.
Patients with severe triple-vessel heart disease showed no significant difference in outcomes between CABG and PCI at five years. The FAME-3 trial enrolled 1,500 patients with triple-vessel disease and found that both procedures performed similarly well, considering recent advances in surgical and minimally invasive techniques.
A new study has found that clopidogrel outperforms aspirin monotherapy in reducing heart attack rates without increasing bleeding risk in high-risk patients following percutaneous coronary intervention (PCI). Researchers observed a significant reduction in ischemic endpoints, primarily driven by a decrease in heart attacks.
A novel AI-powered imaging technique, AngioFFR, has been shown to be comparable to conventional FFR assessment in evaluating patients for PCI. The study found that patients treated with AngioFFR-guided PCI had similar clinical outcomes as those treated with IVUS-guided PCI.
An AI model has been developed to detect blocked coronary arteries based on ECG readings, achieving high accuracy and outperforming expert clinicians. The model could help physicians quickly identify patients who require urgent treatment for a heart attack.
A new study found that three months of dual antiplatelet therapy (DAPT) was better than one month for reducing heart attacks, strokes, and other adverse events without increasing bleeding risk in high-risk patients. For low-risk patients, three months of DAPT was comparable to 12 months in reducing adverse events, while being better th...
A four-year study presented at the American College of Cardiology's Annual Scientific Session found that oral semaglutide reduced cardiovascular death, heart attack, and stroke by 14% compared to a placebo. The drug's benefits are comparable to injectable forms and offer an alternative for patients who prefer not to take injections.
A new clinical trial found that oral semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease. The medication decreased the risk of major cardiac events by 14% compared to placebo, with nonfatal myocardial infarction seeing the greatest reductions in risk.
In an open-label study, patients hospitalized for a serious heart attack who received rivaroxaban or warfarin had similar efficacy and safety outcomes. Rivaroxaban showed comparable results in dissolving left ventricular blood clots at three months follow-up.
A new technique that rapidly increases production of anti-inflammatory cells promotes healing from heart attacks in mice. The researchers developed an infusion method using extracellular vesicles containing the BCYRN1 RNA molecule to boost regulatory T-cell production.
A large study suggests that patients at high risk of heart attacks and strokes should be treated immediately with a combination of a statin and ezetimibe, rather than statins alone. This combination therapy significantly reduces the risk of death from any cause and major adverse cardiovascular events.
TCT 2025 will take place October 25-28, 2025, at the Moscone Center in San Francisco, California. The event will feature acute interventions, breakthrough technologies, and cutting-edge research driving the next era of cardiovascular care.
Two new studies have found a substantial link between cannabis use and an increased risk of heart attack. The studies, one retrospective and one meta-analysis, pooled data from over 4.6 million people, showing that cannabis users under the age of 50 were six times more likely to suffer a heart attack than non-users.
A new study published in Child Maltreatment found that adults who experienced childhood physical and sexual abuse had double the odds of developing health and mental health conditions. The presence of a protective adult in the home was associated with better long-term health outcomes among children who experienced abuse.
A recent study by Professor Mamas highlights the significant risk of cardiovascular diseases (CVD) in patients with cancer, particularly in aging populations. The review emphasizes the need for early diagnosis and regular monitoring to improve quality of life.
A polypill programme combining a statin and three blood pressure lowering drugs could prevent thousands of heart attacks and strokes annually. The approach would be a flagship strategy for disease prevention rather than treatment.
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes focuses on managing unstable angina and myocardial infarction, with recommendations on dual antiplatelet therapy and percutaneous coronary intervention. The guideline also emphasizes the importance of prompt revascularization and se...
A retrospective cohort study from the University of Ottawa and Manitoba found Canadians with hypertension whose preferred language was spoken by their doctor were 36% less likely to have a major adverse cardiovascular event. Patients with language-accessible care had a 28% lower risk of death compared to those without such access.
A new medication approved to treat type 2 diabetes and kidney disease also significantly reduces the risk of heart attacks and strokes among these patients. Sotagliflozin, a sodium-glucose cotransporter inhibitor, blocks proteins that help control blood sugar levels and has been shown to reduce cardiovascular events by 23%.
A large study found that telemedicine and training apps had minimal positive effects on patients with type 2 diabetes and coronary heart disease. The study suggests that direct care from medical professionals remains crucial for improving health outcomes in this population.
A new Northwestern Medicine study reveals that macrophages in newborns use a process called efferocytosis to produce thromboxane, which triggers the production of a bioactive lipid that signals heart muscle cells to divide and regenerate. This process is less effective in adults, leading to scar-tissue buildup and often heart failure.
A study from the University of Gothenburg found that testosterone increases damage following a heart attack by increasing white blood cell release from bone marrow. This affects both men and women, but has a greater impact on male hearts.
The Cardiovascular Research Foundation will host THT 2025, showcasing late-breaking clinical science presentations on transcatheter approaches to managing a wide spectrum of heart failure patients. Four dedicated sessions feature exclusive first-release data from pivotal studies and dynamic discussions on controversies in clinical trials.
Research published in the European Heart Journal found that people with high amounts of intermuscular fat are more likely to develop coronary microvascular dysfunction and future serious heart disease. The study's lead author suggests that existing measures of obesity may not be accurate for all individuals, particularly women.
A Michigan Medicine study suggests that higher out-of-pocket costs for initial cardiac rehabilitation sessions are a major barrier to participation. Patients who shared the cost of their first session attended more sessions than those who paid nothing, but still had lower odds of completing over 24 sessions.
Fran Brown, Syracuse University's 31st head coach, was awarded the Paul 'Bear' Bryant Newcomer Coach of the Year Award for delivering a 10-win season and ranking in every poll. The award recognizes coaches making the sport better through grit, integrity, and a winning approach.
Research led by University of Pittsburgh scientists found that exposure to long-wavelength red light reduces blood clots in humans and mice. The study's findings have the potential to reduce deaths and disabilities caused by blood clots worldwide.
The American Heart Association has named eight active college football coaches as finalists for the prestigious Paul 'Bear' Bryant Coach of the Year Award. The winners will be announced on January 22, 2025, at an awards ceremony presented by Marathon Oil.
A study published in the Journal of the American College of Cardiology found that people exposed to high aircraft noise levels had stiffer and thicker heart muscles, which contracted and expanded less easily. This was especially true for those exposed to higher noise at night, potentially due to impaired sleep and stress responses.
A new study found that exposure to high aircraft noise levels can lead to stiffer and thicker heart muscles, increasing the risk of poor heart function and major cardiac events. People exposed to night-time aircraft noise were particularly at risk, with increased risks of heart attacks, life-threatening rhythms, and strokes.
Researchers found that injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function. The therapy worked by stimulating the proliferation of endogenous pig cardiomyocytes, which had previously been unable to divide in adult hearts.
The American Heart Association has released its list of top cardiovascular research for 2024, focusing on prevention, treatment and the benefits of anti-obesity medications. The research highlights improvements in assessing cardiovascular risk, identifying early prevention opportunities and treating heart failure.
A systematic review and meta-analysis found CAD is common in cirrhotic patients, but cirrhosis itself may not be associated with increased CAD risk. Non-alcoholic steatohepatitis and hepatitis C virus infection are also linked to CAD presence.
The American Heart Association warns hunters about the increased risk of heart attack and stroke due to exertion, cold temperatures, and excitement. Hunters should recognize symptoms, take breaks, and have a plan in case of emergencies. Learning Hands-Only-CPR can also save lives.
Researchers assess 20 years of clinical trials for cell therapy's safety and efficacy in treating heart failure, highlighting progress despite challenges. The field continues to evolve through lessons learned from past studies, with ongoing trials taking novel directions.
Researchers found that certain cancer treatments, such as immune checkpoint inhibitors, can trigger damaging levels of inflammation in the heart and increase risk of heart disease. This is because these treatments interfere with immune regulation in the heart's largest blood vessels.
Researchers analyzed the effects of seven hormone treatments on blood clots, stroke, and heart attack in nearly one million women. The study shows that the risks differ depending on the type of treatment, with some linked to increased cardiovascular disease risk and others to no increased risk.
Knowing family health history is crucial for reducing heart attack and stroke risk. Experts recommend following Life's Essential 8 - five health behaviors and three health factors to lower genetic risks.
A new study maps genetic traits to cellular composition of atherosclerotic plaques, predicting future stroke or heart attack risk. The research improves risk assessment and treatment for patients with atherosclerosis.
Research found that spironolactone reduced the likelihood of heart failure after a heart attack, but did not significantly reduce deaths or other severe heart-related events. The study included over 7,000 adults in 14 countries who had experienced a severe heart attack.
A recent study found that electronic letter reminders highlighting the cardiovascular benefits of influenza vaccines increased vaccination rates among over 2 million adults in Denmark. The strategy showed a greater impact on those who have had a heart attack, improving flu shot rates by potentially being cardioprotective. The research ...
Researchers found that ablation reduced ICD shocks for ventricular tachycardia and episodes of VT not detected by the ICD. This minimally invasive procedure destroys abnormal heart tissue causing VT, offering a better alternative to long-term medication side effects.
A recent study found that intensive systolic blood pressure reduction approaches can significantly reduce the risk of major cardiovascular events in adults with Type 2 diabetes. Lowering systolic blood pressure to less than 120mmHg led to a reduced risk of heart attack, stroke, and death from cardiovascular disease.
A recent study presented at the American Heart Association's Scientific Sessions 2024 found that heart attack survivors experience significant fear and anxiety about having another heart attack. The fear can be triggered by various factors, including new health information and lack of follow-up care. The study highlights the need for e...
Research suggests that GLP-1 receptor agonists and SGLT2 inhibitors, commonly prescribed for Type 2 diabetes or weight loss, may lower the risk of heart attack and recurrent stroke in adults who have had an initial stroke. The study analyzed data from over 7,000 adults with ischemic strokes between 2000 and 2022.
A survey of older adults with heart conditions found that their sexual health impacts mood and well-being, but most healthcare professionals do not offer this information. Patients favor conversations with healthcare professionals about sexual health, including topics like medication side effects and anxiety before sex.
A new study found that beta blockers, commonly used to treat heart attack patients with normal pumping function, may lead to increased depression symptoms. Researchers observed more severe depression symptoms in patients who received beta blockers compared to those who did not.
A new study found that the heart sends signals to the brain to increase sleep after a heart attack, promoting healing and reducing inflammation. This communication between the heart and brain is mediated through the immune system and can lead to improved recovery and reduced risk of further cardiovascular events.
Aging adults face increased risk of life-threatening complications when undergoing elective noncardiac surgeries too soon after a heart attack. Delaying surgery for three to six months following a heart attack can significantly reduce this risk, according to new research published in JAMA Surgery.
A randomized trial found that large-bore mechanical thrombectomy was superior to catheter-directed thrombolysis in reducing clinical deterioration, ICU admissions, and readmissions. LBMT also showed faster symptom improvement and shorter hospital stays compared to CDT.
A study found that using an orbital atherectomy device to remove calcium from blocked coronary arteries before stenting procedures did not improve patient outcomes. The device was used on patients with moderately severe calcification, rather than extreme cases, and did not show significant benefits.
A new study found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis did not reduce the incidence of all-cause death or unplanned aortic stenosis hospitalization. However, it did show benefits in reducing emergency hospitalizations and preventing symptom development.
A randomized trial found early TAVR to be safe and effective for patients with asymptomatic severe AS, reducing the risk of composite endpoints and favorable health status outcomes. Patients who received early TAVR had better left-ventricular and left-atrial health compared to those on clinical surveillance.
Researchers at UCLA have identified the protein GPNMB as a critical regulator in the heart's healing process after a heart attack. GPNMB promotes heart repair by binding to receptor GPR39, triggering a cascade of signals that limit scarring and improve cardiac function.
Scientists at UCLA have engineered an experimental therapy that shows promise in enhancing heart repair following a heart attack, preventing the onset of heart failure. The new single-dose therapy targets the protein ENPP1, which is responsible for increasing inflammation and scar tissue formation.
A study by Dr. Hernan Bazan at Ochsner Health reveals that higher frailty scores are directly associated with increased rates of stroke, death, and myocardial infarction within 30 days of the carotid procedure. The Hospital Frailty Risk Index provides a systematic tool for assessing frailty risk across large populations.
Researchers have found that women are more likely to die from postoperative complications after high-risk cardiovascular surgery, with a failure to rescue rate of 10.7% compared to 8.6% for men. The quality of hospital where the procedure was performed did not affect this disparity.
Biomedical engineer Jeff Saucerman has received a $3.1 million NIH grant to study low-density lipoprotein receptor 1 and its impact on heart failure and treatment outcomes after a heart attack.